Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Kora Corporation Ltd. (trading as Kora Healthcare), Swords Business Park, Swords, Co. Dublin, Ireland
IMUNOVIR 500 mg Tablets.
| Pharmaceutical Form |
|---|
|
White to off-white oblong tablets with a faint amine odour, engraved with a score-line on one side and ‘DN’ on the other. The score-line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each tablet contains 500mg Inosine Acedoben Dimepranol (INN, also known as inosine pranobex*) which is the p-acetamidobenzoic acid salt of N,N-dimethylamino-2-propanol [DIP.PAcBA] and β-inosine in a 3:1 molar ratio.
* British Approved Name (BAN) the non-proprietary designation
Excipient(s) with known effect: each tablet contains 67mg wheat starch.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Inosine pranobex |
Inosine pranobex is a synthetic purine derivative with immunomodulatory and antiviral properties, which result from an apparent in vivo enhancement of host immune responses due to the drug. |
| List of Excipients |
|---|
|
Povidone |
100 (5 × 20) tablets in transparent, colourless PVC/PVDC blister packs sealed with aluminium foil.
Kora Corporation Ltd. (trading as Kora Healthcare), Swords Business Park, Swords, Co. Dublin, Ireland
PL 39972/0001
15th November 1983/29th September 2009
| Drug | Countries | |
|---|---|---|
| IMUNOVIR | Canada, Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
